www.fdanews.com/articles/61261-european-union-s-chmp-adopts-positive-opinion-for-suboxone-buprenorphine-naloxone-for-treatment-of-opioid-dependence
EUROPEAN UNION'S CHMP ADOPTS POSITIVE OPINION FOR SUBOXONE (BUPRENORPHINE/NALOXONE) FOR TREATMENT OF OPIOID DEPENDENCE
July 28, 2006
Schering-Plough Corporation announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has granted a positive opinion recommending approval of SUBOXONE (buprenorphine hydrochloride/naloxone hydrochloride) Sublingual Tablets for the substitution treatment of opioid dependence, within a framework of medical, social and psychological treatment.
Pipeline Review (http://www.pipelinereview.com/joomla/content/view/5498/109/)